If a study has multiple periods, how many kit types should I create?

When a study has both an open-label and blinded period, your process for creating kit types depends on whether kit type descriptions should be visible to blinded users.

• If the kit type description must be visible to blinded Oracle Clinical One Platform users during the open-label period, you have to create 2 kit types for each kit:
  • Create a blinded kit type, which must be dispensed during the blinded period. The kit type description won't be visible to blinded users during this period.
  • Create an unblinded kit type, which must be dispensed during the open-label period. The kit type description will be visible to blinded users during this period.
• If it's okay for the kit type description to never be visible to blinded users, you can create only blinded kit types and dispense them in both the blinded and unblinded periods.